Detailansicht

Wissensnetz

Person

Falko Fend

Pathologe

Name	Falko Fend
Ort	Tübingen (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Pathologe (charakteristischer Beruf)
Weitere Angaben	ärztlicher Direktor, Abteilung Allgemeine Pathologie, Universitätsklinikum Tübingen
Datensatztyp	Person
GND-Nummer	112383363X
Datensatz-ID	112383363X
Beteiligt an alle anzeigen High iASPP (PPP1R13L) expression is an independent predictor of adverse clinical outcome in acute myeloid leukemia (AML) Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma Molekulare Diagnostik des vitreoretinalen Lymphoms Klonale Hämatopoese und Knochenmarkinfiltration bei Patienten mit einem nodalen Lymphom der T-follikulären Helferzellen Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients Diagnostic and prognostic molecular pathology of lymphoid malignancies Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution—a proof of principle study Klassifikation peripherer T-Zell-Lymphome : Neuigkeiten und offene Fragen Prevalence of IRF4 rearrangement in large B-cell lymphomas of the Waldeyer’s ring in adults Implementing deep learning models for the classification of Echinococcus multilocularis infection in human liver tissue Molecular profiling of EBV associated diffuse large B-cell lymphoma Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age Data-driven development of sparse multi-spectral sensors for urological tissue differentiation Divergent effects of EZH1 and EZH2 protein expression on the prognosis of patients with T-cell lymphomas Plasma cell neoplasms and related entities—evolution in diagnosis and classification A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy EBV-assoziierte lymphoproliferative Erkrankungen CD147 a direct target of miR-146a supports energy metabolism and promotes tumor growth in ALK+ ALCL Lymphome des Auges und seiner Adnexe : Moderne pathologische Diagnostik und systemische Therapie Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies? Biobanking in times of crisis – The COVID-19 Autopsy and Biosample Registry Baden-Wuerttemberg Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1 Intracranial hemorrhage in COVID-19 patients during extracorporeal membrane oxygenation for acute respiratory failure : a nationwide register study report Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies? Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies? Recurrence Score® result impacts treatment decisions in hormone receptor-positive, HER2-negative patients with early breast cancer in a real-world setting - results of the IRMA trial The pulmonary pathology of COVID-19 Klonalitätsanalyse in der Praxis Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation Correction to: Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program Memento for interprofessional learning Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integration Comprehensive in situ analysis of ALDH1 and SOX2 reveals increased expression of stem cell markers in high-grade serous carcinomas compared to low-grade serous carcinomas and atypical proliferative serous tumors Clonal evolution of chronic lymphocytic leukemia to Langerhans cell histiocytosis: a case report Assessment of concomitant non-oncologic medication in patients with surgically treated renal cell carcinoma: impact on prognosis, cell-cycle progression and proliferation The pathological features of angioimmunoblastic T-cell lymphomas with IDH2 R172 mutations Therapeutic targets and microenvironment in sequential biopsies of classical Hodgkin lymphoma at diagnosis and relapse The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma Therapeutic targets and microenvironment in sequential biopsies of classical Hodgkin lymphoma at diagnosis and relapse Langerhans cell histiocytosis associated with classical Hodgkin lymphoma contains BRAF V600E mutation Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma Diagnosis of Richter transformation in chronic lymphocytic leukemia: histology tips the scales Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma—a feasibility study using full slide staining The t(14;18) translocation is absent from endothelial and follicular dendritic cells of follicular lymphoma (FL) and shows heterogeneous presence in preserved FL mantle zones Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma Non-invasive papillary urothelial carcinoma of the vagina: molecular analysis of a rare case identifies clonal relationship to non-invasive urothelial carcinoma of the bladder Tumor Heterogeneity in Lymphomas: A Different Breed L1CAM: amending the “low-risk” category in endometrial carcinoma HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Falko Fend

High iASPP (PPP1R13L) expression is an independent predictor of adverse clinical outcome in acute myeloid leukemia (AML)

Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations

Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas

Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma

Molekulare Diagnostik des vitreoretinalen Lymphoms

Klonale Hämatopoese und Knochenmarkinfiltration bei Patienten mit einem nodalen Lymphom der T-follikulären Helferzellen

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

Diagnostic and prognostic molecular pathology of lymphoid malignancies

Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution—a proof of principle study

Klassifikation peripherer T-Zell-Lymphome : Neuigkeiten und offene Fragen

Prevalence of IRF4 rearrangement in large B-cell lymphomas of the Waldeyer’s ring in adults

Implementing deep learning models for the classification of Echinococcus multilocularis infection in human liver tissue

Molecular profiling of EBV associated diffuse large B-cell lymphoma

Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age

Data-driven development of sparse multi-spectral sensors for urological tissue differentiation

Divergent effects of EZH1 and EZH2 protein expression on the prognosis of patients with T-cell lymphomas

Plasma cell neoplasms and related entities—evolution in diagnosis and classification

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy

EBV-assoziierte lymphoproliferative Erkrankungen

CD147 a direct target of miR-146a supports energy metabolism and promotes tumor growth in ALK+ ALCL

Lymphome des Auges und seiner Adnexe : Moderne pathologische Diagnostik und systemische Therapie

Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?

Biobanking in times of crisis – The COVID-19 Autopsy and Biosample Registry Baden-Wuerttemberg

Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age

Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age

HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1

Intracranial hemorrhage in COVID-19 patients during extracorporeal membrane oxygenation for acute respiratory failure : a nationwide register study report

Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?

Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?

Recurrence Score® result impacts treatment decisions in hormone receptor-positive, HER2-negative patients with early breast cancer in a real-world setting - results of the IRMA trial

The pulmonary pathology of COVID-19

Klonalitätsanalyse in der Praxis

Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment

STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma

The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation

Correction to: Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program

Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program

Memento for interprofessional learning

Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model

Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model

A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integration

Comprehensive in situ analysis of ALDH1 and SOX2 reveals increased expression of stem cell markers in high-grade serous carcinomas compared to low-grade serous carcinomas and atypical proliferative serous tumors

Clonal evolution of chronic lymphocytic leukemia to Langerhans cell histiocytosis: a case report

Assessment of concomitant non-oncologic medication in patients with surgically treated renal cell carcinoma: impact on prognosis, cell-cycle progression and proliferation

The pathological features of angioimmunoblastic T-cell lymphomas with IDH2 R172 mutations

Therapeutic targets and microenvironment in sequential biopsies of classical Hodgkin lymphoma at diagnosis and relapse

The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma

The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma

Therapeutic targets and microenvironment in sequential biopsies of classical Hodgkin lymphoma at diagnosis and relapse

Langerhans cell histiocytosis associated with classical Hodgkin lymphoma contains BRAF V600E mutation

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma

Diagnosis of Richter transformation in chronic lymphocytic leukemia: histology tips the scales

Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma—a feasibility study using full slide staining

The t(14;18) translocation is absent from endothelial and follicular dendritic cells of follicular lymphoma (FL) and shows heterogeneous presence in preserved FL mantle zones

Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma

Non-invasive papillary urothelial carcinoma of the vagina: molecular analysis of a rare case identifies clonal relationship to non-invasive urothelial carcinoma of the bladder

Tumor Heterogeneity in Lymphomas: A Different Breed

L1CAM: amending the “low-risk” category in endometrial carcinoma

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy